Leuven, Vlaams-Brabant, Belgium The fund was located in Europe if to be more exact in Belgium. The main department of described Corporate Investor is located in the Leuven.
The top amount of exits for fund were in 2017. The common things for fund are deals in the range of 1 - 5 millions dollars. Comparing to the other companies, this Fidimec performs on 4 percentage points more the average number of lead investments. The fund is generally included in less than 2 deals every year. The important activity for fund was in 2016.
Among the most popular fund investment industries, there are Telecommunications, Software. Among the various public portfolio startups of the fund, we may underline Indigo Diabetes, Trinean Moreover, a startup needs to be at the age of 6-10 years to get the investment from the fund. The fund has no specific favorite in a number of founders of portfolio startups. For fund there is a match between the country of its foundation and the country of its the most frequent investments - Belgium.
The standard case for the fund is to invest in rounds with 5 partakers. Despite the Fidimec, startups are often financed by Vesalius Biocapital Partners, Capital-E, Baekeland Funds. The meaningful sponsors for the fund in investment in the same round are PMV, Capricorn Venture Partners, Baekeland Funds.
Related Funds
| Fund Name | Location |
| 4SC | Bayern, Germany, Planegg |
| AE Jarrah Capital Group | - |
| Bejo Ventures | - |
| China Reform Holdings Corporation | Beijing, Beijing, China |
| Core Mobility | California, Mountain View, United States |
| Dabu Investment | China, Guangdong, Shenzhen |
| Entertaindom.com | Burbank, California, United States |
| The CFO Consulting | Japan, Tokyo |
| Walnut Venture Associates | Massachusetts, United States, Wellesley |
| Zap Ventures | California, Los Altos Hills, United States |
Notable deals
| Company | Industry | Round Size | Date | Investors | Location |
Sentea | $2M | 07 Oct 2021 | Oost-Vlaanderen, East Flanders, Belgium | ||
Indigo Diabetes | $44M | 27 Jul 2020 | Belgium, East Flanders | ||
MICLEDI Microdisplays | $5M | 09 Jan 2020 | Belgium, Flemish Brabant | ||
Aloxy | $2M | 07 Sep 2018 | Antwerp, Antwerp, Belgium | ||
Indigo Diabetes | $8M | 20 Dec 2016 | Ghent, East Flanders, Belgium |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data Latest deals
| Company | Industry | Round Size | Date | Investors | Location |
Sentea | $2M | 07 Oct 2021 | Oost-Vlaanderen, East Flanders, Belgium | ||
Indigo Diabetes | $44M | 27 Jul 2020 | Belgium, East Flanders | ||
MICLEDI Microdisplays | $5M | 09 Jan 2020 | Belgium, Flemish Brabant | ||
Aloxy | $2M | 07 Sep 2018 | Antwerp, Antwerp, Belgium | ||
Indigo Diabetes | $8M | 20 Dec 2016 | Ghent, East Flanders, Belgium |
